Results for tag: "Simulect"

The Simulect market is a subset of the immunosuppressive drug market, which is composed of drugs used to suppress the immune system. These drugs are used to prevent the body from rejecting transplanted organs, as well as to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease. Simulect is a specific type of immunosuppressive drug, which is used to prevent organ rejection in transplant patients. It works by blocking the action of certain white blood cells, which are responsible for attacking foreign tissue. The Simulect market is highly competitive, with many companies offering similar products. Some of the major players in the market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Other companies in the market include Astellas Pharma, Sanofi, and GlaxoSmithKline. Show Less Read more